22 research outputs found

    Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease - A 16-week randomized, double-blind, placebo-controlled study

    No full text
    Rosiglitazone therapy improves insulin sensitivity and glucose uptake in patients with uncomplicated type 2 diabetes. In coronary artery disease (CAD), glucose is an important source of energy and preserved myocardial glucose uptake is essential for the viability of jeopardized myocardium. The aim was to test whether rosiglitazone changes myocardial metabolism in type 2 diabetic patients with CAD. We studied 54 patients (38 men and 16 women) with type 2 diabetes (HbA(1c) 7.2 + 0.9%) and CAD. Myocardial glucose uptake was measured with [F-18]fluoro-2-deoxy-D-glucose positron emission tomography in ischemic (evaluated by single-photon emission tomography and coronary angiography) and nonischemic regions during euglycemic-hyperinsulinemic clamp before and after a 16-week intervention period with rosiglitazone (n = 27) or placebo (n = 27). Rosiglitazone significantly improved glycemic control (P <0.0001) and whole-body insulin sensitivity (P <0.0001). Rosiglitazone increased myocardial glucose uptake from 20.6 +/- 11.8 to 25.5 +/- 12.4 mu mol center dot 100 g(-1). min(-1) (P = 0.038 vs. baseline, P = 0.023 vs. placebo) in ischemic regions and from 21.7 +/- 12.1 to 28.0 +/- 12.7 mu mol center dot 100 g(-1) center dot min(-1) (P = 0.014 vs. baseline, P = 0.003 vs. placebo) in nonischemic regions. The increase in myocardial glucose uptake was partly explained by the suppression of free fatty acid levels during clamp. Rosiglitazone therapy significantly increased insulin sensitivity and improved myocardial glucose uptake in type 2 diabetic patients with CAD. These results suggest that rosiglitazone therapy may facilitate myocardial glucose storage and utilization in these patients

    Accounting for habitat when considering climate: has the niche of the Adonis blue butterfly changed in the UK?

    Get PDF
    The dramatic recovery of three species of grassland specialist butterfly threatened with extinction at their high latitude range limits in the 1980s has been attributed to two factors: increased grazing on calcareous grassland sites and warmer air temperatures. Both result in the warming of soil surface temperatures, favourable to the larvae of these species. We address the influence of both of these factors on the habitat usage of the butterfly Polyommatus bellargus, undergoing recovery at its northern range edge. We test the hypothesis that the larval niche of P. bellargus has become less constrained in the past three decades, whilst controlling for changes in habitat structure. Once habitat change has been accounted for we find no evidence for a broadening of the larval niche of P. bellargus. Further, we show that coincident with the recovery of P. bellargus there have been drastic reductions in average turf height across UK chalk grasslands, but changes in air temperature have been highly variable. We conclude that changes to soil surface temperatures caused by reducing turf heights will have been a more consistent influence than air temperature increases, and so habitat improvements through increased grazing will have been the major driver of recovery in P. bellargus. We consider the need to account for changes in habitat when exploring the impacts of recent climate change on local habitats in thermophilous species, and emphasise the continued importance of habitat management to support such species under variable local climates
    corecore